Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Morlock

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Cureus|December 4, 2023
Think Before You Ink: Perception, Prevalence, and Correlates of Tattooing and Tattoo Regret in US AdultsRobert Morlock, Amy Morlock
Pain Reports|February 3, 2018
Pharmacoeconomics of genotyping-based treatment decisions in patients with chronic painRobert Morlock, Glenn D Braunstein
Journal of Health Economics and Outcomes Research|July 21, 2020
Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation ModelPeter Wahlqvist, Jay Warner, Robert Morlock
ACR Open Rheumatology|November 6, 2024
Gout Flare Burden in the United States: A Multiyear Cross-Sectional Survey StudyJasvinder A Singh, Amy Morlock, Robert Morlock
Current Therapeutic Research, Clinical and Experimental|January 28, 2014
A revised estimate of the burden of illness of goutAlbert Wertheimer, Robert Morlock, Michael A Becker
Ecancermedicalscience|January 26, 2019
Targeted literature review of the global burden of gastric cancerMontserrat Casamayor, Robert Morlock, Hiroshi Maeda, et al.
World Journal of Nephrology|May 26, 2017
Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based studySylvie Perreault, Javier Nuevo, Scott Baumgartner, et al.
Plos One|January 22, 2021
COVID-19 prevalence and predictors in United States adults during peak stay-at-home ordersRobert Morlock, Amy Morlock, Martha Downen, et al.
Clinical Therapeutics|April 16, 2013
Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysisRobert Morlock, Bridgett Goodwin, Gabriel Gomez Rey, et al.
The Journal of Sexual Medicine|April 14, 2022
Sexual Satisfaction Results With the Vaginal pH Modulator From the Phase 3 AMPOWER StudyMichael A Thomas, Robert Morlock, Clint Dart, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Cureus|December 4, 2023
Think Before You Ink: Perception, Prevalence, and Correlates of Tattooing and Tattoo Regret in US AdultsRobert Morlock, Amy Morlock
Pain Reports|February 3, 2018
Pharmacoeconomics of genotyping-based treatment decisions in patients with chronic painRobert Morlock, Glenn D Braunstein
Journal of Health Economics and Outcomes Research|July 21, 2020
Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation ModelPeter Wahlqvist, Jay Warner, Robert Morlock
ACR Open Rheumatology|November 6, 2024
Gout Flare Burden in the United States: A Multiyear Cross-Sectional Survey StudyJasvinder A Singh, Amy Morlock, Robert Morlock
Current Therapeutic Research, Clinical and Experimental|January 28, 2014
A revised estimate of the burden of illness of goutAlbert Wertheimer, Robert Morlock, Michael A Becker
Ecancermedicalscience|January 26, 2019
Targeted literature review of the global burden of gastric cancerMontserrat Casamayor, Robert Morlock, Hiroshi Maeda, et al.
World Journal of Nephrology|May 26, 2017
Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based studySylvie Perreault, Javier Nuevo, Scott Baumgartner, et al.
Plos One|January 22, 2021
COVID-19 prevalence and predictors in United States adults during peak stay-at-home ordersRobert Morlock, Amy Morlock, Martha Downen, et al.
Clinical Therapeutics|April 16, 2013
Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysisRobert Morlock, Bridgett Goodwin, Gabriel Gomez Rey, et al.
The Journal of Sexual Medicine|April 14, 2022
Sexual Satisfaction Results With the Vaginal pH Modulator From the Phase 3 AMPOWER StudyMichael A Thomas, Robert Morlock, Clint Dart, et al.
Pageof 5